BIS monitoring in Dexmedetomidine infusion during laproscopic surgeries to reduce sevoflurane requirement

A prospective randomised controlled study utilising Bispecrtal index guidance to investigate the impact of Dexmedetomidine on Sevoflurane consumption during elective laproscopic surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092194

Enrollment

Registered

2025-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: effect of Dexmedetomidine infusion in laproscopic surgeries: To study the effect of Dexmedetomidine on sevoflurane consumption using BIS monitoring in laproscopic surgeries Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: patient giving valid informed consent ASA 1 and ASA 2 MP 1 and MP2 Elective laproscopic surgeries BMI- 18.5 TO 24.9

Exclusion criteria

Exclusion criteria: patient refusal ASA 3 and ASA 4 Age less than 20 and above 65 patient with ischemic and rheumatic heart disease patients on alpha agonist, antagonist and beta blockers allergies to medications

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Dexmedetomidine on sevoflurane requirements during elective laproscopic surgeriesTimepoint: From 0 minutes of dexmedetomidine infusion till the end of procedure	—

Secondary

Measure	Time frame
Assessment of the hemodynamic parameters and thereby enabling the titration of the anesthetic agent based on BIS monitoringTimepoint: From 0 min of administration to 90 mins post administration	—

Countries

India

Contacts

Public ContactDr Harshini T

Vinayaka Missions Kirupananda Variyar Medical College and Hospitals Chinnaseeragapadi Salem

naveenasen@gmail.com6382660052

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026